| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.77 | 0.004 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.31 | 0.3 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.29 | 0.3 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.26 | 6e-05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.26 | 0.0001 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.25 | 0.05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.24 | 0.0001 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.24 | 0.07 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.2 | 0.003 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.2 |